首页 正文

Bergenin exerts anti-cancer activity in hepatocellular carcinoma via the PI3K/Akt/mTOR and MAPK/ERK pathways

{{output}}
Objective: Hepatocellular carcinoma (HCC) remains a therapeutic challenge with limited treatment options. This study investigated the anti-tumor potential of bergenin, a bioactive acylated iridoid glycoside, against HCC and eluci... ...